Wednesday, 27 December 2017

66th Article " Curcumi-piperine/curcumin-quercetin/curcumin-silibinin dual drug-loaded nanoparticulate combination therapy : A novel approach to target and treat multidrug-resistant cancers."


Nur fatmawati
16611047

Curcumi-piperine/curcumin-quercetin/curcumin-silibinin dual drug-loaded nanoparticulate combination therapy : A novel approach  to target and treat multidrug-resistant cancers.

Multidrug resistance (MDR) is the mechanism which many cancer develop resistance to chemotherapy drug, resulting in minimal cell death and the expansion of drug-resistant tumors. To address problem of resistance, researchers have developed nanoparticles that simultaneously deliver chemotherapy drugs to tumors and inhibit the MDR proteins that pump the therapeutic drugs out of the cell. The process is known as chemosensitization, as blocking this resistance renders the tumor highly sensitive to the cancer-killing chemotherapy. Curcumin is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric, a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.

No comments:

Post a Comment